MedPath
TGA Approval

AKYNZEO IV fosnetupitant (as chloride hydrochloride)/palonosetron (as hydrochloride) 235 mg/250 microgram concentrated injection vial (349310)

349310

AKYNZEO IV fosnetupitant (as chloride hydrochloride)/palonosetron (as hydrochloride) 235 mg/250 microgram concentrated injection vial

Juniper Biologics Pty Ltd

January 28, 2022

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/34c1e54545e8d23513fa40b7a84872f5.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/345437e5391dc97349db09aa9afa9f1b.pdf

Active Ingredients

fosnetupitant chloride hydrochloride

palonosetron hydrochloride

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

AKYNZEO IV fosnetupitant (as chloride hydrochloride)/palonosetron (as hydrochloride) 235 mg/250 microgram concentrated injection vial (349310) - TGA 批准文号 | MedPath